本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corcept醫療

111.81
+0.99000.89%
盤後111.810.00000.00%19:30 EDT
成交量:66.86萬
成交額:7,478.64萬
市值:120.86億
市盈率:246.47
高:113.60
開:110.82
低:110.49
收:110.82
52周最高:126.38
52周最低:28.66
股本:1.08億
流通股本:9,644.01萬
量比:0.64
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):0.4537
每股收益(LYR):0.8200
淨資產收益率:8.23%
總資產收益率:0.47%
市淨率:17.13
市盈率(LYR):136.35

資料載入中...

2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities